DCMIC
ALPN

Decheng Capital Management III (Cayman)’s Alpine Immune Sciences Inc ALPN Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$76.8M Buy
+6,708,288
New +$82.6M 25.63% 1
2022
Q4 		– Sell
-6,708,288
Closed -$48.3M – 28
2022
Q3 		$48.3M Buy
6,708,288
+2,000,000
+42% +$16.5M 17.51% 1
2022
Q2 		$40.1M Hold
4,708,288
– – 15.19% 2
2022
Q1 		$42.2M Buy
+4,708,288
New +$40.7M 12.94% 3

Other funds holding ALPN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Decheng Capital Management III (Cayman)'s ALPN Position: Q3 2023 in Review

Decheng Capital Management III (Cayman) opened a new position in Alpine Immune Sciences Inc (ALPN) in Q3 2023: 6,708,288 shares worth $76.8M. The stake represents 25.63% of the portfolio and ranks #1 among its holdings. This is a return to the name: Decheng Capital Management III (Cayman) previously reported a position in ALPN as recently as Q3 2022.

Decheng Capital Management III (Cayman) first reported a position in ALPN in Q1 2022 and has held it in 4 quarters since. 88 funds tracked by Wall St. Rank hold ALPN as of Q3 2023.

  • Decheng Capital Management III (Cayman) held 6,708,288 shares of Alpine Immune Sciences Inc worth $76.8M as of Q3 2023.
  • Alpine Immune Sciences Inc was a new Decheng Capital Management III (Cayman) position in Q3 2023.
  • Alpine Immune Sciences Inc made up 25.63% of Decheng Capital Management III (Cayman)'s portfolio in Q3 2023, its #1 holding.
  • Decheng Capital Management III (Cayman) first reported a position in Alpine Immune Sciences Inc in Q1 2022 and has held it in 4 quarters since.
  • 88 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2023.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q3 2023, filed 13 Nov 2023.